SIA "FuturaPharm"
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2025-12-29
Change in officers2025-10-07
Change in officers2024-12-18
Change in beneficial owners2024-12-18
Change of equity capitalSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
3Debts
1,912.72 €
+1,912.72 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
0
Credit limit
***** €
Turnover
30-50 k €
+100.00 %Business linkages
12Linkages with other companies
Financial ratios
Net Profit (€)
-57,988
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
-57,988EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2022 |
|---|
| 0 |
| - |
| -49 |
| -99 |
| - |
| - |
| - |
| -615 |
| 814 |
| 0 |
| 199 |
| 2023 |
|---|
| 0 |
| 0 |
| -5,996 |
| -5,996 |
| -5,996 |
| - |
| - |
| -6,611 |
| 18,826 |
| 12,000 |
| 215 |
| 2024 |
|---|
| 46,116 |
| 15,372 |
| -57,542 |
| -57,988 |
| -19,329 |
| -0.55 |
| -125.74 |
| -17,399 |
| 57,995 |
| 9,600 |
| 30,996 |
Enjoy unlimited use
with Freemium unlimited| 2024 |
|---|
| 46,116 |
| 15,372 |
| -57,542 |
| -57,988 |
| -19,329 |
| -0.55 |
| -125.74 |
| -17,399 |
| 57,995 |
| 9,600 |
| 30,996 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2024
Turnover (€)
46,116 €
- *
Sales per employee (€)
15,372 €- *
Profit before tax (€)
-57,542 €
-860 % *
Net Profit (€)
-57,988 €-867 % *
Profit per employee (€)
-19,329 €-222 % *
Total profitability (%)
-0.55 %- *
Net profitability (%)
-125.74 %- *
Equity (€)
-17,399 €-163 % *
Amounts Payable And Liabilities (€)
57,995 €
208 % *
Non-current Assets (€)
9,600 €
-20 % *
Current Assets (€)
30,996 €14,317 % *
Credit history
No. of unpaid debts
1
Largest debt
VID
Amount of unpaid debts
€1,912.72
Oldest open debt
-
No. of unpaid debts
1
Largest debt
VID
Amount of unpaid debts
€1,912.72
Oldest open debt
-
Credit report
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(0)
Plaintiff
(0)
SIA "FuturaPharm" has no court cases
SIA "FuturaPharm" has no registered court cases as defendant or plaintiff within the last 2 years.
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 50 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 50 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 50 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 50 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: -290 |
Similar companies
Category:
Research and experimental development in natural sciences and engineeringComp. code:
40203692999Reg. date:
29/10/2025Turnover:
-No. of employees:
2Category:
Research and experimental development in natural sciences and engineeringComp. code:
50203578981Reg. date:
01/08/2024Turnover:
-No. of employees:
3Category:
Research and experimental development in natural sciences and engineeringComp. code:
40203564481Reg. date:
24/05/2024Turnover:
-No. of employees:
2Category:
Research and experimental development in natural sciences and engineeringComp. code:
40203551665Reg. date:
28/03/2024Turnover:
-No. of employees:
2Category:
Research and experimental development in natural sciences and engineeringComp. code:
40203543206Reg. date:
26/02/2024Turnover:
-No. of employees:
3Frequently Asked Questions
What is the current status of SIA "FuturaPharm"?
SIA "FuturaPharm" is currently Registered. It was registered on 19/09/2014.
What is SIA "FuturaPharm" registered address?
SIA "FuturaPharm" registered address is Kalnciema iela 27 – 1, Rīga, LV-1083.
What is SIA "FuturaPharm" activity?
SIA "FuturaPharm" operates in Research and experimental development in natural sciences and engineering (72.10 - NACE 2.1).
How many employees does SIA "FuturaPharm" have?
SIA "FuturaPharm" has 3 employees (2024).
Is SIA "FuturaPharm" a reliable company?
SIA "FuturaPharm" Pre-Score* rating is D, which indicates a low level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.What is the annual turnover of SIA "FuturaPharm"?
SIA "FuturaPharm" reported a turnover of 46,116 EUR in 2024.
Does SIA "FuturaPharm" have any current state debt?
SIA "FuturaPharm" currently has an outstanding state debt of 1,912.72 €.